3-Phenyl-Substituted Imidazo[1,5-a]quinoxalin-4-ones and Imidazo[1,5-a]quinoxaline Ureas That Have High Affinity at the GABAA/Benzodiazepine Receptor Complex

A series of imidazo[1,5-a]quinoxalin-4-ones and imidazo[1,5-a]quinoxaline ureas containing substituted phenyl groups at the 3-position was developed. Compounds within the imidazo[1,5-a]quinoxaline urea series had high affinity for the GABAA/benzodiazepine receptor complex with varying in vitro effic...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 39; no. 19; pp. 3820 - 3836
Main Authors Jacobsen, E. Jon, Stelzer, Lindsay S, Belonga, Kenneth L, Carter, Donald B, Im, Wha Bin, Sethy, Vimala H, Tang, Andrew H, VonVoigtlander, Philip F, Petke, James D
Format Journal Article
LanguageEnglish
Published Washington, DC American Chemical Society 13.09.1996
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A series of imidazo[1,5-a]quinoxalin-4-ones and imidazo[1,5-a]quinoxaline ureas containing substituted phenyl groups at the 3-position was developed. Compounds within the imidazo[1,5-a]quinoxaline urea series had high affinity for the GABAA/benzodiazepine receptor complex with varying in vitro efficacy, although most analogs were partial agonists as indicated by [35S]TBPS and Cl- current ratios. Interestingly, a subseries of piperazine ureas was identified which had biphasic efficacy, becoming more antagonistic with increasing concentration. Analogs within the imidazo[1,5-a]quinoxalin-4-one series had substantially decreased binding affinity as compared to the quinoxaline urea series. These compounds ranged from antagonists to full agonists by in vitro analysis, with several derivatives having roughly 4-fold greater intrinsic activity than diazepam as indicated by Cl- current measurement. Numerous compounds from both series were effective in antagonizing metrazole-induced seizures, consistent with anticonvulsant properties and possible anxiolytic activity. Most of the quinoxaline ureas and quinoxalin-4-ones were active in an acute electroshock physical dependence side effect assay in mice precluding further development.
Bibliography:ark:/67375/TPS-TX8Q0R1M-Z
Abstract published in Advance ACS Abstracts, August 15, 1996.
A portion of this material was presented at the 207th American Chemical Society National Meeting, March 13−17, 1994.
istex:F72DFB76677A217FB00E3C24FB715BD6C832C802
ISSN:0022-2623
1520-4804
DOI:10.1021/jm960070+